Sign inJoin waitlistJoin the waitlist

AL

Anne Marie Langevin

Professor · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine

Credentials: · · ·

History

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present

Pediatric Hematology-Oncology
1983–1984
Pediatrics
1980–1983
Doctor of Medicine
1976–1980

Research

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning…
Journal of Clinical Oncology · 2016 · 168 citations
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children
New England Journal of Medicine · 1990 · 136 citations
Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race
Pediatric Blood & Cancer · 2010 · 98 citations

Aaron Sugalski
6 papers
Susan Blaney
6 papers
Jacques Baillargeon
5 papers
JM
Judith Mullins
5 papers
AP
Aaron Pitney
4 papers
Allison Grimes
4 papers
JE
Jaime Estrada
4 papers
David Dickens
3 papers
GK
Gideon Koren
3 papers
Holcombe Grier
3 papers
Michael Roth
3 papers
RD
Ronald Dubowy
3 papers

Grants

Texas Pediatric NCORP
National Cancer Institute · UG1
Contact PI · $11M · University of Texas Hlth Science Center
2014–2027
South Texas Pediatric Minority Based CCOP
National Cancer Institute · U10
Contact PI · $4M · University of Texas Hlth Science Center
1990–2014

Clinical trials

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Study chair · Completed · Phase 2
National Cancer Institute (NCI)
2000
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2025–2029
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Site PI · Recruiting · Phase 1, Phase 2
Tanja Andrea Gruber
2023–2033